NORA

Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77

Retrieved on: 
Tuesday, December 5, 2023

The company's proprietary Airmod system, an active noise-canceling electronic stethoscope that seamlessly integrates with AI, enables continuous monitoring of patients' breathing sounds.

Key Points: 
  • The company's proprietary Airmod system, an active noise-canceling electronic stethoscope that seamlessly integrates with AI, enables continuous monitoring of patients' breathing sounds.
  • In collaboration with Taiwan's major medical centers and teaching hospitals, Heroic Faith has collected over 1.6 million entries of breathing sound data for AI training.
  • Heroic Faith's new General Manager, Yuan-Ren Cheng, has recently updated the company's motto from 'Saving Lives Through Innovation' to 'Saving Lives Through Communication.'
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/saving-lives-through-communicat...
    SOURCE Heroic Faith Medical Science, Inc.

Surgical Directions Addresses Anesthesia Provider Shortages with Innovative Solutions

Retrieved on: 
Wednesday, November 15, 2023

CHICAGO, Nov. 15, 2023 /PRNewswire/ -- Surgical Directions , the nation's premier clinician-driven, perioperative, anesthesia, technology, and workforce solutions organization, is taking proactive steps to address the critical issue of anesthesia provider shortages affecting hospitals nationwide.

Key Points: 
  • CHICAGO, Nov. 15, 2023 /PRNewswire/ -- Surgical Directions , the nation's premier clinician-driven, perioperative, anesthesia, technology, and workforce solutions organization, is taking proactive steps to address the critical issue of anesthesia provider shortages affecting hospitals nationwide.
  • Dr. Jason Klopotowski, MD, Lead Physician Managing Director at Surgical Directions, has outlined innovative strategies to combat these shortages and enhance the efficiency of surgical services.
  • Integrate Non-OR Anesthesia (NORA) Locations: Streamline NORA schedules and coordinate them with the main OR schedule to avoid spikes in anesthesia demand, optimizing anesthesia resources.
  • For healthcare executives seeking solutions to the anesthesia crisis and improved OR performance, Surgical Directions offers innovative strategies and actionable recommendations.

BASF celebrates 10 years of its Northeast Research Alliance

Retrieved on: 
Thursday, May 25, 2023

Since its inception, NORA has evolved to stay competitive and drive innovation in the Massachusetts ecosystem. It expanded from a single university model with Harvard in 2008 to include MIT and the University of Massachusetts Amherst in 2013. NORA continued to expand in 2017 through BASF’s partnership with Greentown Labs -- the largest climatetech startup incubator in North America -- based in nearby Somerville, MA.

Key Points: 
  • At the conference, BASF announced its plans to expand the scope of NORA to include additional partners such as startups, accelerators, customers, research institutes, and other universities across North America to strengthen its innovation ecosystem.
  • NORA will stand for the North America Open Research Alliance moving forward.
  • “Harvard, MIT, UMass, and Greentown Labs will continue to play a leading role in the partnership between BASF and the broader innovation ecosystem in North America,” said Dr. Detlef Kratz, President of Group Research, BASF SE.
  • More than 100 postdocs and students and 47 faculty members have been involved in these projects, closely collaborating with key experts within BASF.

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

Retrieved on: 
Wednesday, February 22, 2023

One presentation will feature an ad hoc interim OS data analysis of the Phase 3 NORA trial, showing how niraparib maintenance therapy with an individualized starting dose (ISD) provided a favorable OS (OS; secondary endpoint) trend versus placebo in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC) regardless of biomarker status.

Key Points: 
  • One presentation will feature an ad hoc interim OS data analysis of the Phase 3 NORA trial, showing how niraparib maintenance therapy with an individualized starting dose (ISD) provided a favorable OS (OS; secondary endpoint) trend versus placebo in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC) regardless of biomarker status.
  • The median overall survival (mOS) in the niraparib-treated group was numerically higher (46.3 months) compared to 43.4 months in placebo [HR=0.82; 95% CI, 0.56-1.21].
  • This new data analysis explores the treatment effect of niraparib versus placebo on OS adjusted for subsequent poly (ADP-ribose) polymerase inhibitor (PARPi) use in the placebo group.
  • Another presentation will feature a post hoc analysis from the randomized, double-blind, placebo-controlled Phase 3 PRIME trial, with results showing niraparib associated with improved progression-free survival (PFS) regardless of surgical timing and residual disease status compared with placebo in patients with newly diagnosed advanced ovarian cancer in China.

Ukrainian physicians on the frontline amongst 900 presenters at the 20th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT) in LA

Retrieved on: 
Wednesday, February 1, 2023

LOS ANGELES, Feb. 1, 2023 /PRNewswire/ -- Last year, the Society for Brain Mapping and Therapeutics (SBMT) established a task force to help Ukraine with medical humanitarian missions including engaging physicians and neurosurgeons in combat casualty care and medical supply support. This year, the Ukrainian Medical Team supported by SBMT will present their work at the 20th Annual World Congress of SBMT (Brain, Spine and Mental Health) at the LA Convention Center on Feb. 16-19, 2023.  

Key Points: 
  • This year, the Ukrainian Medical Team supported by SBMT will present their work at the 20th Annual World Congress of SBMT (Brain, Spine and Mental Health) at the LA Convention Center on Feb. 16-19, 2023.
  • "We are using our convention to not only advance the neurotechnology to treat neuropsychiatric, spine and brain disorders but impact people in war zones through our humanitarian missions."
  • Said, Dr. Vicky Yamamoto, 20th President, Executive Director of SBMT, and a cancer scientist at Keck School of Medicine of USC.
  • The Convention will have two Keynote panels on "Advanced Cancer Therapy" and "The Psychology of the Brain and Gun Violence."

National Online Retailers Association Recognises ClearSale as Top Anti-Fraud Solution

Retrieved on: 
Tuesday, December 6, 2022

Global ecommerce fraud protection leader, ClearSale ( www.clear.sale ), has been honored with an award from National Online Retailers Association ( NORA ).

Key Points: 
  • Global ecommerce fraud protection leader, ClearSale ( www.clear.sale ), has been honored with an award from National Online Retailers Association ( NORA ).
  • Named the Best Security/Anti-Fraud solution at the 4th Annual NORA Solution Partner Awards, ClearSale is thrilled to celebrate the recognition from the Australia and New Zealand ecommerce industries.
  • The NORA Network awards bring together members of the retail ecosystem and celebrate the achievements of solution partners in the industry.
  • Were thrilled to be recognised by NORA, its advisory board, and retailers as the top anti-fraud solution for Australian and New Zealand ecommerce businesses, said Rafael Lourenco, EVP of ClearSale.

Zai Lab to Present Analysis of the Impact of Timing for ZEJULA® (niraparib) Maintenance Treatment in Newly Diagnosed Advanced Ovarian Cancer at the 2022 International Gynecologic Cancer Society Meeting

Retrieved on: 
Tuesday, September 20, 2022

The initiation timing of niraparib maintenance treatment had no significant impact on its safety profile.

Key Points: 
  • The initiation timing of niraparib maintenance treatment had no significant impact on its safety profile.
  • This subgroup analysis provides evidence to support the initiation of niraparib maintenance treatment in patients with newly diagnosed advanced ovarian cancer within 12 weeks after chemotherapy completion.
  • This study further supports ZEJULA as an important maintenance treatment therapy after platinum-based chemotherapy in people with advanced ovarian cancer.
  • Ovarian cancer is one of the most common gynecologic cancers inChina,with over 55,000 newly diagnosed cases and 37,000 deaths inChina annually1.

Foqus TV Selects Setplex OTT Platform to Scale IPTV-Based Musical Television Programming and Content

Retrieved on: 
Thursday, September 1, 2022

Utilizing the Setplex end-to-end OTT platform, Foqus TV will be able to offer and scale a broad range of original programming from independent artists, among other programs, to its global audience.

Key Points: 
  • Utilizing the Setplex end-to-end OTT platform, Foqus TV will be able to offer and scale a broad range of original programming from independent artists, among other programs, to its global audience.
  • Setplex provides a comprehensive, single-source platform to deliver OTT and IPTV content and programming .
  • Utilizing the Setplex platform, Foqus TV is uniquely positioned to deliver a broad range of free and ad-supported content that can easily scale to accommodate millions of subscribers, added Lionel Dreshaj, Co-Founder and CEO of Setplex.
  • Customers like Foqus TV rely on Setplex because of its highly flexible platform which supports multiple business models such as PPV, AVOD, SVOD and TVOD.

Hilco Real Estate Announces Online-Only Auction of 25± Commercial & 90± Residential Properties throughout New Orleans on Behalf of the New Orleans Redevelopment Authority

Retrieved on: 
Tuesday, July 26, 2022

The auctioneer is Hilco Real Estate, LLC, in conjunction with licensed Louisiana broker and auctioneer Paul A. Lynn, CCIM.

Key Points: 
  • The auctioneer is Hilco Real Estate, LLC, in conjunction with licensed Louisiana broker and auctioneer Paul A. Lynn, CCIM.
  • For this auction we will also be offering 25 Commercial sites," stated Fernando Palacios, managing director with Hilco Real Estate.
  • Hilco Real Estate advises and executes strategies to help both healthy and distressed clients maximize the value of their real estate assets.
  • Follow Hilco Real Estate on social media for the latest news and opportunities:

Mary Kay Inc. Expands Partnership With The Nature Conservancy to Protect Biodiversity and Marine Resources

Retrieved on: 
Tuesday, June 7, 2022

We are very excited to partner with The Nature Conservancy to tackle the loss of wild native oyster (Ostrea edulis).

Key Points: 
  • We are very excited to partner with The Nature Conservancy to tackle the loss of wild native oyster (Ostrea edulis).
  • With support from funders like Mary Kay, TNC can restore and protect these important systems for the long term.
  • Mary Kays partnership with TNC and the NORA network will support projects that protect biodiversity and marine resources across Europe.
  • Mary Kay is proud to support The Nature Conservancys work to help reintroduce the native European oyster to restore critical marine biodiversity, said Deborah Gibbins , Mary Kays Chief Operating Officer.